Hudson Canyon Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Hold |
2,418
| – | – | 0.79% | 52 |
|
|
2025
Q1 | $1.53M | Buy |
2,418
+99
| +4% | +$62.8K | 1.08% | 50 |
|
|
2024
Q4 | $1.65M | Hold |
2,319
| – | – | 1.08% | 45 |
|
|
2024
Q3 | $2.44M | Hold |
2,319
| – | – | 1.58% | 20 |
|
|
2024
Q2 | $2.44M | Sell |
2,319
-307
| -12% | -$323K | 1.65% | 17 |
|
|
2024
Q1 | $2.53M | Hold |
2,626
| – | – | 1.63% | 20 |
|
|
2023
Q4 | $2.31M | Sell |
2,626
-57
| -2% | -$50.1K | 1.68% | 21 |
|
|
2023
Q3 | $2.21M | Hold |
2,683
| – | – | 1.81% | 17 |
|
|
2023
Q2 | $1.93M | Sell |
2,683
-84
| -3% | -$60.4K | 1.52% | 27 |
|
|
2023
Q1 | $2.27M | Sell |
2,767
-144
| -5% | -$118K | 1.91% | 9 |
|
|
2022
Q4 | $2.1M | Sell |
2,911
-164
| -5% | -$118K | 1.94% | 13 |
|
|
2022
Q3 | $2.12M | Sell |
3,075
-310
| -9% | -$214K | 2.11% | 10 |
|
|
2022
Q2 | $2M | Sell |
3,385
-297
| -8% | -$176K | 1.93% | 12 |
|
|
2022
Q1 | $2.57M | Hold |
3,682
| – | – | 2.03% | 11 |
|
|
2021
Q4 | $2.33M | Buy |
3,682
+196
| +6% | +$124K | 1.69% | 20 |
|
|
2021
Q3 | $2.11M | Sell |
3,486
-127
| -4% | -$76.9K | 1.62% | 24 |
|
|
2021
Q2 | $2.02M | Sell |
3,613
-12
| -0.3% | -$6.7K | 1.51% | 32 |
|
|
2021
Q1 | $1.72M | Buy |
3,625
+275
| +8% | +$130K | 1.35% | 43 |
|
|
2020
Q4 | $1.62M | Buy |
+3,350
| New | +$1.62M | 1.29% | 46 |
|